Condition
Skeletal Dysplasia
Total Trials
6
Recruiting
2
Active
3
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Active Not Recruiting1
Completed1
Terminated1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05247645RecruitingPrimary
Data Collection of Patients With Rare Bone Diseases
NCT03548779Not ApplicableCompleted
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
NCT05991609Active Not RecruitingPrimary
Extreme Morphology and Metabolic Health
NCT06002373UnknownPrimary
Assessment of Artificial Intelligence for Treatment Decision Recommendation of Adult Skeletal Class III Patients
NCT05876416Recruiting
Decoding the Genetic Landscape of Skeletal Diseases
NCT02762318TerminatedPrimary
Identification and Characterization of Bone-related Genetic Variants in Families
Showing all 6 trials